Latest Governance News

Mammoth Minerals has completed key US gold project acquisitions and launched exploration drilling, backed by a $5 million capital raise and strategic board appointments.

Red Metal Limited reports significant progress across its rare earth, gold, and copper projects, alongside a $16 million capital injection into its Maronan Metals subsidiary. Key drilling and metallurgical studies set the stage for resource upgrades and scoping studies in 2026.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Yugo Metals has raised $3.5 million to fund its first-ever diamond drilling program targeting gold anomalies at its Sinjakovo project in Bosnia. The company also advances community and regulatory engagement for its Sockovac license while maintaining a cautious cash position.

AGL Energy has agreed to purchase four new gas turbines for $185 million to develop the Kwinana Swift Gas 2 project, securing 176MW of reserve capacity to support Western Australia’s energy transition.

Knosys Limited reported robust Q1 FY26 results with $3.5 million in cash receipts and a steady $9.5 million annual recurring revenue, while advancing its AI-driven Libero X product and appointing a new Chair.

Capstone Copper delivered a landmark Q3 2025 with record revenue, lowest-ever cash costs, and a strategic joint venture that derisks its Santo Domingo project. The company’s growth trajectory is bolstered by robust production gains and promising exploration results.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Resmed Inc. kicked off fiscal 2026 with robust 9% revenue growth and a notable 290 basis points gross margin expansion, signaling strong momentum in home healthcare innovation. The company also declared a $0.60 dividend and executed a $150 million share buyback, underscoring confidence in its strategic direction.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW, secures $34 million through capital raising, and acquires promising US exploration assets, setting the stage for growth.

WhiteHawk Limited reports steady Q3 revenue and advances key contracts, positioning itself to capitalise on new U.S. cybersecurity compliance rules.